These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8927235)

  • 21. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M; Shibasaki T; Masuda A; Imaki T; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome.
    Fukudo S; Nomura T; Hongo M
    Gut; 1998 Jun; 42(6):845-9. PubMed ID: 9691924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebroventricular injection of corticotropin-releasing hormone in the pig: acute effects on behavior, adrenocorticotropin secretion, and immune suppression.
    Johnson RW; von Borell EH; Anderson LL; Kojic LD; Cunnick JE
    Endocrinology; 1994 Aug; 135(2):642-8. PubMed ID: 8033811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loperamide, an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease.
    Bochicchio D; Ambrosi B; Faglia G
    Neuroendocrinology; 1988 Dec; 48(6):611-4. PubMed ID: 2855105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Administration of Ghrelin and Corticotropin-Releasing Hormone in the Diagnosis of Cushing's Disease.
    Miljić D; Polovina S; Doknić M; Pekić S; Stojanović M; Petakov M; Micić D; Popović V
    Neuroendocrinology; 2017; 104(1):33-39. PubMed ID: 26836811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mifepristone: effect on plasma corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol in term pregnancy.
    Byrne JD; Wing DA; Fraser M; Fassett MJ; Goodwin TM; Challis JR
    J Perinatol; 2004 Jul; 24(7):416-20. PubMed ID: 15152270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man.
    Born J; Späth-Schwalbe E; Schwakenhofer H; Kern W; Fehm HL
    J Clin Endocrinol Metab; 1989 May; 68(5):904-11. PubMed ID: 2541159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells.
    Rehman KS; Sirianni R; Parker CR; Rainey WE; Carr BR
    Reprod Sci; 2007 Sep; 14(6):578-87. PubMed ID: 17959886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
    Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
    Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone.
    Tomori N; Suda T; Nakagami Y; Tozawa F; Sumitomo T; Ushiyama T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):87-93. PubMed ID: 2535853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary.
    Zerbe CA; Clark TP; Sartin JL; Kemppainen RJ
    Neuroendocrinology; 1993; 57(2):282-8. PubMed ID: 8389997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects.
    Allolio B; Schulte HM; Deuss U; Winkelmann W
    Horm Metab Res Suppl; 1987; 16():36-8. PubMed ID: 2832287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responsivity of the baboon fetal pituitary to corticotropin-releasing hormone in utero at midgestation.
    Berghorn KA; Albrecht ED; Pepe GJ
    Endocrinology; 1991 Sep; 129(3):1424-8. PubMed ID: 1651849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin-releasing hormone is not the sole factor mediating exercise-induced adrenocorticotropin release in humans.
    Smoak B; Deuster P; Rabin D; Chrousos G
    J Clin Endocrinol Metab; 1991 Aug; 73(2):302-6. PubMed ID: 1649838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.